Mario Allaire (@allairemar73316) 's Twitter Profile
Mario Allaire

@allairemar73316

ID: 1891488451486269441

calendar_today17-02-2025 14:03:06

60 Tweet

59 Followers

26 Following

Mario Allaire (@allairemar73316) 's Twitter Profile Photo

This is what it should look like in terms of approval for NWBO example of a press release from MHRA . Breast Cancer HER-2 from ROCHE GO GO Nwbo , we are next We have zero toxicity $nwbo nwbo NWBO gov.uk/government/new…

Mario Allaire (@allairemar73316) 's Twitter Profile Photo

$nwbo nwbo NWBO Added 40K shares today , as the trading is telling us a different patern lately. Still think we are going to see a blue sky situation soon. as we all deserve it being extremely patient. It’s Christmas time

Mario Allaire (@allairemar73316) 's Twitter Profile Photo

$nwbo Nwbo Here is what the reality is based on the facts Go go go Nwbo DCVax-L | CHM Nov 27–28 — the regulatory reality DCVax-L is under the UK 150-day accelerated approval pathway. The CHM meeting on Nov 27–28 occurred around Day ~143–145 — the final decision window. At

Richard Fairgrieve (@richfairgrieve) 's Twitter Profile Photo

Siobhain McDonagh Wes Streeting National Institute for Health and Care Research Cancer Research UK And to think the MHRAgovuk has been in possession of an MAA from $NWBO for $DCVax-L to treat one of the deadliest forms of cancer, GBM, for over 2 years and still hasn't approved it. $DCVax is a safe and effective treatment yet languishes in a government morass. Shameful.